Leaders in Pharmaceutical Business Intelligence (LPBI) Group

MassBio 2015 Annual Meeting, March 26-27, 2015, Royal Sonesta Hotel, Cambridge, MA

 

Reporter: Aviva Lev-Ari, PhD, RN

 http://www.massbio.org/events/calendar/3000-massbio_annual_meeting_2015/event_detail

Keynote Speakers Just Announced! Andrew Lo  Charles E. and Susan T. Harris Professor and Director, MIT Laboratory for Financial Engineering  and Kathy Giusti Founder & Executive Chairman, Multiple Myeloma Research Foundation

 AGENDA

MassBio Annual Meeting 2015        
Thursday, March 26     

8:00 am – 9:00 am    Breakfast and Registration

9:00 am – 9:30 am    Welcome Remarks & MassBio Board Elections  

• Jay Ash, Secretary of Housing and Economic Development,  Commonwealth of Massachusetts.

9:30 am – 10:15 am    Keynote: Kathy Guisti, Founder & Executive Chairman of the Multiple Myeloma Research Foundation    

10:15 am – 10:30 am    Coffee Break

10:30 am – 11:30 am    Breakout sessions
Better Business Track:    It’s Not Your Grandfather’s Manufacturing    

• Geoff Hodge, Leader, Fast Trak Solutions, GE Healthcare Life Sciences
• Ralph Lambalot, Vice President, Biologics Development, AbbVie
• David Smith, Head, Cell Therapy Manufacturing, Lonza
• Bayan Takizawa, Co-Founder & Chief Business Officer, Continuus Pharma

Trends in Science Track: From Bioterrorism to Superorganisms: Perils, Pitfalls, and Promise

• Chris Garabedian, President & CEO, Sarepta
• Steve Gilman
• David Lubner, CFO, Tetraphase

11:45 am – 1:30 pm    The MassBio Annual Awards Luncheon

• Henri A. Termeer Innovative Leadership Award – Presented to Mark Levin, Partner, Third Rock Ventures
• Joshua Boger Innovative School of the Year Award
• Leading Impact Award

1:30 pm – 2:20 pm    Precision Medicine: Who’s Paying?    

• David Altshuler, Executive Vice President of Global Research and Chief Scientific Officer, Vertex
• Walter Carney, Chief Scientific Officer, Nuclea Diagnostics
• Sue Hagar, VP Communications and Government Affairs, Foundation Medicine

2:25 pm – 3:15 pm    Breakout sessions

Better Business Track: Externalizing Pharma R&D    

• Thomas Luby, Senior Director of New Ventures , Johnson & Johnson
• John Orloff, ‎Global Head of Research and Development, Baxter

Trends in Science Track: Trends in Healthcare Technology

• Zen Chu, Managing Director of Accelerated Medical Ventures, MIT

3:15 pm – 3:30 pm    Coffee break

3:30 pm – 4:20 pm    Breakout sessions

Better Business Track: Technology Transfer: Status Quo, Evolution, or Revolution?  

• Zafrira Avnur, Global Head Academic Innovation, Roche
• Chris Coburn, Vice President, Innovation, Partners HealthCare
• Erik Halvorson, Senior Director, Technology Transfer & Industry Collaborations, Tufts University

Trends in Science Track: Immunotherapy: Oncology and Beyond

• Mani Mohindru, Vice President of Oncology Strategy, Curis, Inc.
• Anna Protopapas, President & CEO, Mersana
• Phil Vanik,  General Manager for Cell Therapy Technologies, GE Life Sciences
• Leslie Williams, President & CEO, ImmusanT, Inc.

4:20 – 6:30 pm        Networking Reception

Friday, March 27

8:00 am – 8:40 am    Breakfast

8:40 am – 9:30 am    Breakout sessions

Better Business Track: Innovative Ways to Fund Your Early Stage Company    

Panelists:

• Navroze Alphonse, Managing Member, Crossover Capital Management LLC
• Ellen Baron, Managing Director, Healthios
• Walter Capone, President & CEO, MMRF
• Yuval Cohen, CEO, Corbus Pharmaceuticals
• Rick Jones, Broadview Ventures
• William Whelan, Co-Chair, Life Sciences Practice, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, PC

Trends in Science Track: Current and Future Impact of Editing, CART and Gene Therapy

• Nessan Bermingham, CEO, Intellia Therapeutics
• Kevin Bitterman, Partner, Polaris
• Katrine Bosley, CEO, Editas Medicine
• Nick Leschly, chief bluebird, bluebird bio

9:40 am – 10:30 am    Breakout sessions

Better Business Track: The Evolving Reimbursement Landscape

• Steve Miller, Senior Vice President & Chief Medical Officer, Express Scripts
• Lowell Schnipper, Chief, Division of Hematology and Oncology at Beth Israel Deaconess Medical Center

Trends in Science Track: Neuroscience Therapeutics Development: Challenges, Opportunities and the Road Ahead

• Richard Mohs, Vice President for Neuroscience Clinical Development, Eli Lilly
• Rajesh Ranganathan, Director, Office of Translational Research, National Institute for Neurological Disorders and Stroke, National Institutes of Health
• Jonathan Solomon, President & CEO, NeuroPhage Pharmaceuticals
• Rudolph Tanzi, Vice-Chair, Neurology; Director, Genetics and Aging Research Unit, Harvard Medical School

10:30 am – 11:00 am    Coffee Break

11:00 am – 12:00 pm    Defining Value

• Sarah Emond, COO, lnstitute for Clinical and Economic Review
• Chris Hansen, President, American Cancer Society Cancer Action Network, Inc.
• William Sibold, Senior Vice President, Head of Multiple Sclerosis, Genzyme

12:00 pm – 12:45pm    Buffet Lunch

12:45 pm – 1:30 pm    Keynote: Andrew Lo, Charles E. and Susan T. Harris Professor and Director of the MIT Laboratory for Financial Engineering

1:30 pm – 2:00 pm    Dessert Buffet & Networking Reception

SOURCE

http://www.massbio.org/events/calendar/3000-massbio_annual_meeting_2015/event_detail/627

http://campaign.r20.constantcontact.com/render?ca=30306dbe-c9a8-44c1-b2ce-59c62b55a688&c=dfc86d20-ba93-11e3-9f84-d4ae527536d1&ch=dffa5290-ba93-11e3-9fab-d4ae527536d1

 

ANNOUNCEMENT

LEADERS IN PHARMACEUTICAL BUSINESS INTELLIGENCE will cover the

MassBio 2015 Annual Meeting, March 26-27, 2015, Royal Sonesta Hotel, Cambridge, MA

 

event for the Scientific and Business Press. Dr. Lev-Ari will be in attendance on 3/26/2015 and 3/27/2015

 

Venture Overview Updated in New Company Page on LinkedIn:Leaders in Pharmaceutical Business Intelligence

http://pharmaceuticalintelligence.com/2015/03/07/venture-overview-updated-on-new-company-page-on-linkedin-leaders-in-pharmaceutical-business-intelligence/